Why Cardiology Trials Lose Time at Screening and How Patiro Reduces That Risk
Cardiology recruitment often breaks at screening. Many candidates look eligible based on the index diagnosis, then fail on diabetes, uncontrolled blood pressure, CKD, arrhythmias, anticoagulants, or other exclusion drivers that only show up once someone pulls labs and medication history. Sites then work through volume to find a small number of protocol-fit participants, and timelines take the hit.
Patiro reduces that risk by validating fit earlier. We build cardiology-specific pre-screening around the criteria that drive screen failure in real charts, including comorbidity patterns, lab thresholds, prior procedures, and concomitant meds.
The Comorbidity Problem in Cardiology Screening
Cardiology protocols often carry tight safety criteria. Most cardiovascular patients do not present with a single condition, so exclusion risk is built into the population.
High screen failure creates operational drag. Coordinators spend time on calls, chart review, and rescheduled screening visits, then document failures that were predictable from the start.
Enrollment representativeness is also a recurring issue. In NIH-funded cardiovascular disease trials, median enrollment of women was 39%, and few protocols specified recruitment targets for women. Referral-only recruitment rarely changes that pattern.
Patiro’s Experience in Cardiology Clinical Trials
Patiro's cardiology work starts with how patients enter care and how sites confirm eligibility. We design outreach and pre-screening around the variables that tend to rule people out, so sites see fewer low-probability referrals once screening calendars fill.
Sponsors also ask if we can bring experience from other complex indications where comorbidity and polypharmacy are common. We have supported studies in Type 2 Diabetes, Polycythemia Vera, Myelofibrosis, and MDS (Myelodysplastic Syndromes), where older patient populations, concurrent medications, and elevated thrombotic or cardiovascular risk shape how eligibility and referral pathways need to be built.
Why Partner With Patiro for Your Cardiology Trial?
Patiro supports cardiology trials through full-service delivery or FSP models for site management and recruitment operations. We run direct-to-patient digital recruitment and pair it with referral and community channels to reach patients outside specialist pipelines.
You get visibility into recruitment and site performance through our user-friendly patient management platform, with real-time visibility and tracking of volume, conversion, and screen failure reasons. Budget risk is reduced through a Pay Only per Enrolled Patient model. You pay for enrolled participants, not for activity that does not convert.
Contact us to discuss how we can help with clinical trial recruitment for your cardiology trial.
Frequently Asked Questions
How does Patiro reduce screen failure in cardiology clinical trials?
We reduce screen failure in caridology trials by building pre-screening around the protocol criteria that typically drive ineligibility in cardiovascular populations, then qualify candidates before they reach sites. Coordinators spend more time on patients with a realistic path to enrollment.
Do you provide site support or only patient recruitment?
Both. We support site activation and day-to-day recruitment operations through full-service or FSP models, based on your study team’s needs.
Do you support device trials as well as drug trials?
Yes. Patiro supports medical device, procedure, and drug trials, including structural heart and other device-based cardiology studies. Device trials often bring their own eligibility and workflow considerations, like prior device history or anatomical criteria, and we build pre-screening around those specifics rather than applying a drug-trial template to a device study.
How do you handle multi-country cardiology patient recruitment?
We run centralized oversight with local execution so messaging, pre-screening, and referral pathways match local care patterns and local regulatory expectations.
How does your pricing model work?
Patiro offers a pay-per-enrolled-patient model, meaning sponsors only pay for enrolled participants rather than referral volume. By doing this we ensure budget risk is low and it aligns Patiro's incentives directly with the sponsor's enrollment goals.
How fast can you start cardiology patient recruitment?
How fast we can start cardiology patient recruitment and launch timing hinges on how clear the protocol is, which geographies are involved, and the site plan. Once pre-screening and referral pathways are confirmed, Patiro can mobilise quickly. Having supported rescue studies where enrollment had already fallen behind, we know how to move fast without compromising referral quality.
